Lanean...

Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™

Aplidin™ (APL) is a new antitumoral drug from marine origin currently in phase II clinical trials against a wide multiplicity of cancers. As resistance may be, as with other drugs, an important obstacle to the APL therapeutic efficacy, we have established an acquired resistance cellular model by con...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Losada, A, López-Oliva, J M, Sánchez-Puelles, J M, García-Fernández, L F
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2004
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409906/
https://ncbi.nlm.nih.gov/pubmed/15365569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602166
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!